ANN LACEY: Open Payments
NPI 1346509833 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,076 in 94 payments from 26 companies in 2025. Trend: 2023 $1,135 · 2024 $1,898 · 2025 $2,076
Food & beverage: $2,076
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $273 |
| AstraZeneca Pharmaceuticals LP | 4 | $269 |
| Lilly USA, LLC | 12 | $167 |
| PFIZER INC. | 8 | $147 |
| ABBVIE INC. | 8 | $147 |
| GlaxoSmithKline, LLC. | 7 | $139 |
| Amgen Inc. | 11 | $135 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $119 |
| Eisai Inc. | 4 | $97 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $77 |
Products named: Ozempic, BREZTRI, LifeVest, TRELEGY ELLIPTA, PREVNAR 20, Leqembi, JARDIANCE, LEQVIO.
Industry payments across AZ — which companies pay providers there.
